XML 37 R45.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-based Compensation - Additional Information (Detail)
$ in Millions
9 Months Ended
Sep. 30, 2015
USD ($)
plan
shares
Sep. 30, 2014
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of equity compensation plans | plan 2  
Stock-based awards, shares granted 1,081,000  
Restricted stock, shares issued 99,027 0
2013 Omnibus incentive plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity awards 5,729,068  
Stock-based awards, shares granted 1,081,000 1,211,700
2005 Aerie Pharmaceutical stock plan and 2013 omnibus incentive plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized compensation expense | $ $ 26.9  
Compensation cost, weighted average recognition period 2 years 7 months  
Options outstanding, weighted average remaining contractual life 8 years 1 month  
Restricted stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized compensation expense | $ $ 2.0  
Restricted stock awards, weighted average remaining contractual term 3 years 1 month  
Restricted stock, shares issued 99,027  
Restricted stock | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based awards, vesting period 2 years  
Restricted stock | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based awards, vesting period 4 years